LONG-TERM ANTIVIRAL MANAGEMENT OF HCV AND HIV-1 COINFECTED SUBJECTS (SLAM-C)

HCV 和 HIV-1 双重感染受试者的长期抗病毒治疗 (SLAM-C)

• 批准号: 7716808
• 负责人: DAVID A WOHL
• 金额: $ 0.73万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-02 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716808
• 关键词: Antiviral Agents; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Hepatitis C; Hepatitis C virus; Institution; Liver; Purpose; Rate; Research; Research Personnel; Resources; Source; United States National Institutes of Health; peginterferon alfa-2a

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to find out if long-term treatment with pegylated-interferon alfa-2a (PEG-IFN) slow the rate of liver damage caused by hepatitis C in people who did not get rid of the hepatitis C virus with previous treatment.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究的目的是找出长期使用聚乙二醇干扰素α-2a（PEG-IFN）治疗是否可以减缓丙型肝炎引起的肝损伤的速度，这些人在以前的治疗中没有摆脱丙型肝炎病毒。